CAMBRIDGE, Mass.--(BUSINESS WIRE)--Euthymics Bioscience, Inc. today announced that Thomas A. Shea has been appointed Chief Financial Officer. Mr. Shea brings Euthymics decades of biopharmaceutical industry experience, and has spent the last 12 years serving as CFO of biotechnology companies in the Boston area.
